Pacific Biosciences of California Stock Price and Value Analysis

Should you buy Pacific Biosciences of California stock? (NasdaqGS:PACB). Let's see how it does in our automated value investing analysis system.

PACB Free Cash Flow Trend

Free Cash Flow trendline for PACB
Free Cash Flow trendline for Pacific Biosciences of California

Hmm, we can't give any reliable projection for Pacific Biosciences of California's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This company is solid.
  • This company has fluctuating growth.
  • This stock looks overpriced.
  • This company is not making money.
  • This company pays no dividend.

Inside the PACB Numbers

PACB Price
(Pacific Biosciences of California stock price per share)
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Diagnostics & Research stocks
[?] Cash Yield -9.36%
[?] Free Cash Flow Jitter 25%

Is Pacific Biosciences of California Stock on Sale?

Based on our analysis, we believe that you should not buy Pacific Biosciences of California right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy PACB Stock?

Does Pacific Biosciences of California have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.